Document is current
Any future updates will be listed below
-
Authors
Känkänen, Voitto
Hirvonen, Sami-Pekka
Teesalu, Tambet
Hirvonen, Jouni
Balasubramanian, Vimalkumar
Santos, Hélder A. https://orcid.org/0000-0001-7850-6309
-
Funding
Funding for this research was provided by:
University of Helsinki
- License Information
-
More Information
Article History
Accepted: 7 December 2024
First Online: 3 January 2025
Declarations
:
: The experiments comply with the current laws of the country in which they were performed.
: All authors have read and agreed to the published version of the manuscript.
: V. Balasubramanian is an employee at Bayer Oy (Finland). V. Känkänen was employed at Bayer Oy (Finland) during a part of this work. Tambet Teesalu is the inventor of a patent related to the linTT1 peptide titled “Targeted delivery system and methods of use therefor” (publication number: 10669311). The other authors declare no other competing financial interests.
